Type 3 antenatal Bartter syndrome presenting with mild polyuria

  1. Yuto Otsubo ,
  2. Yuji Kano ,
  3. Hiroshi Suzumura and
  4. Shigemi Yoshihara
  1. Department of Pediatrics, Dokkyo Medical University, Shimotsuga-gun, Tochigi, Japan
  1. Correspondence to Dr Yuto Otsubo; otsubo.920315@gmail.com

Publication history

Accepted:19 Mar 2021
First published:07 Apr 2021
Online issue publication:07 Apr 2021

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Bartter syndrome (BS) is a well-recognised inherited tubular dysfunction that causes polyuria, metabolic alkalosis and hypokalaemia. Among BS cases, antenatal/neonatal BS (ABS) usually shows distinct polyhydramnios prenatally and presents features of BS in the early neonatal period. We encountered a premature infant with type 3 ABS presenting with mild polyuria and discuss the pathogenesis of mild polyuria in type 3 ABS. A male infant was born at 31 weeks’ gestation. His mother received amniocentesis because of polyhydramnios. Hyponatraemia and hypokalaemia appeared within 3 days after birth. Metabolic alkalosis, hyperreninaemia and hyperaldosteronism were also identified. Temporary polyuria developed at 1 month after birth; however, the mean urine output during hospitalisation was within the normal range. CLCNKB compound heterozygous mutations were confirmed. Polyuria of type 3 ABS may be less severe than in other types of ABS. Lower urine sodium loss may be a characteristic feature of type 3 ABS.

Background

Bartter syndrome (BS) is a disease of inherited tubular dysfunction with metabolic alkalosis and hypokalaemia. BS is classified as type 1–5 due to related genes. Type 4 is further classified as types 4a and 4b.1 BS is also classified by the time of onset. Antenatal/neonatal BS (ABS) develops during the fetal and neonatal periods and classic BS develops in infancy or early childhood. ABS causes polyhydramnios due to polyuria from the foetal period, which can lead to preterm delivery. After birth, excessive polyuria is the most striking symptom of ABS.2 We experienced a rare case of a preterm male infant born at 31 weeks’ gestation with type 3 ABS presenting with mild polyuria. We discuss the pathogenesis of mild polyuria in type 3 ABS.

Case presentation

A male infant was born at 31 weeks’ gestation by labour onset due to chorioamnionitis. His Apgar score was 5, 8 and 9 at 1, 5 and 10 min, respectively. His birth weight and its SD scores (SDS) were 1755 g (+0.4 SDS), and he was admitted to the neonatal intensive care unit requiring prematurity management. Written informed consent for participation in this study was obtained from the patient’s parents.

The patient’s mother was diagnosed with polyhydramnios. Her amniotic fluid index was 30 cm at 23 weeks’ gestation, and she received amniocentesis once. Premature rupture of membrane developed at 28 weeks’ gestation; however, the amniotic fluid volume was not reduced.

Investigations

Blood tests on admission showed an elevated inflammatory response with a white blood cell count of 11.4 ×109 /L (12% and 21% bacillary and segmental nuclei neutrophils, respectively) and C reactive protein level of 10.47 mg/dL. Based on placental pathology, the patient was diagnosed with intrauterine infection due to chorioamnionitis. He was treated with ampicillin and gentamicin, and antimicrobial therapy was completed 6 days after birth.

Postnatal weight loss of 1479 g was observed at 3 days after birth, which corresponded to 16% wt loss compared with the birth weight.

Hyponatraemia (134 mEq/L) and hypokalaemia (3.3 mEq/L) were observed on days one and three, respectively (table 1). Infusion containing sodium and potassium chloride was started at 2 days of age, and oral sodium and potassium chloride supplements were started and increased as intravenous infusion was tapered. Metabolic alkalosis (pH, 7.446; PCO2, 47.0 mm Hg; Base excess, +7.0 mmol/L; HCO3-, 31.9 mmol/L), hyperreninaemia (370 ng/mL/hour) and hyperaldosteronism (1340 pg/mL) were also detected at 8 days of age; therefore, the diagnosis of ABS was confirmed. Serum sodium gradually increased to within the normal range, but hypokalaemia did not recover. After sodium chloride supplementation, urine sodium levels were 39–96 mEq/L.

Table 1

Biochemical characteristics during hospitalisation

Days after birth 0 1 2 3 4 8 16 22 29 43 57 67
Venous BGA
 pH 7.224 7.394 7.388 7.388 7.446 7.452 7.427 7.45 7.433 7.564 7.454
 Base Excess (mmol/L) −1.2 0.5 −0.6 1.6 7 6.9 7.1 4.4 8.7 11.3 6.6
 Bicarbonate (mmol/L) 28.7 24.3 23.7 28.6 31.9 31.5 32.3 28.3 33.7 34.5 30.9
Plama
 Sodium (mmol/L) 140 134 133 131 128 128 132 137 135 142 138 138
 Potassium (mmol/L) 6.5 6.1 4.6 3.7 3.6 3.2 3.6 2.9 3 3.6 3.1 3.9
 Chloride (mmol/L) 102 96 92 90 87 80 89 93 93 96 92 91
 Creatinine (mg/dL) 0.57 0.83 0.8 0.69 0.66 0.42 0.34 0.3 0.29 0.27 0.2 0.17
Urines
 Sodium (mmol/L) 39 68 69 71 96 84 86 50
 Potassium (mmol/L) 31 48 56 60 45 107 84 67
 Chloride (mmol/L) 48 101 115 127 143 142 129 114
 Calcium to creatinine ratio 1.0 1.1 1.9 2.0 0.4 0.5 0.6
 Creatinine (mg/dL) 15 13 9 7 7 19 12 14
  • BGA, blood gas analysis.

Outcome and follow-up

The patient was treated with sodium chloride, potassium chloride and spironolactone; thereafter, laboratory data were within the normal range. The patient was discharged at 69 days of age without failure to thrive, and his weight at discharge was 2840 g (−0.3 SDS). Temporary polyuria (urine output, 5.3 mL/kg/hr) developed at 1 month after birth; however, the mean urine output during hospitalisation was within the normal range (urine output, 4.3 mL/kg/hour; figure 1). There was no nephrocalcinosis at admission, but it developed on day 19 and remained until discharge.

Figure 1

Mean urine output chart each weeks’ postmenstrual age.

Genetic analysis revealed compound heterozygous mutations of CLCNKB. Both parents had heterozygous variants: exons 1–3 deletion in the mother and all exon deletions in the father. Based on these results, he was diagnosed with type 3 BS.

Discussion

We experienced a preterm infant with type 3 ABS. Polyuria was temporary, and the mean urine output during hospitalisation was within the normal range, which was exceptional for ABS. Type 3 ABS is more likely to have mild polyuria than other types.

The patient developed mild polyuria. The normal urine output of new-borns is 1.25–2.5 mL/kg/hour at day 0, and gradually rises to 2–3 mL/kg/hour.3 In the literature, we could not find any definition of polyuria in neonates, especially for preterm neonates. In the literature on diabetes insipidus, the definition of polyuria was ≥5 mL/kg/hour.4 In another study on diabetes insipidus, polyuria was defined as a urine output of 4 mL/kg/hour in children and 6 mL/kg/hour in neonates.5 In this case, the patient had temporary polyuria of 5.3 mL/kg/hour from 35 to 36 weeks postmenstrual age. The average urine output during hospitalisation was 4.3 mL/kg/hour, which was higher than normal, but did not meet the definition of polyuria. As is evident from the above, polyuria was mild.

Polyuria of type 3 ABS may be milder than in other types. From an investigation of 146 children with all types of ABS, patients with types 3 and 4 ABS had the lowest urine output (5 mL/kg/hour). On the other hand, the urine outputs were 7, 6 and 15 mL/kg/h for types 1, 2 and 5 ABS, respectively.6

Polyuria in ABS can occur during the foetal period, resulting in polyhydramnios, which leads to a high incidence of preterm births.2 The average gestational age at delivery for type 3 ABS was 37 weeks, while the average gestational age at delivery for all other types of ABS was 29–33 weeks.6 7 In a study of 34 children with type 3 ABS, the average gestational age at delivery was reported to be 37 weeks, and amniotic fluid overload was reported to be the main symptom in only 56% of cases.7 In a report on 42 cases of ABS, including six cases of type 3 ABS, only two cases with type 3 ABS did not present polyhydramnios.8 Amniocentesis occurred once for types 3 and 4a ABS, compared with twice for types 1, 2 and 5.6 These findings suggest that type 3 ABS can develop mild polyuria, which leads to a low chance of polyhydramnios and preterm births. This patient had a premature birth due to chorioamnionitis, but the urine output was mild even in the preterm period. There have been few reports of preterm infants with type 3 ABS so far; therefore, our case is valuable for the research of type 3 ABS.

Less urine sodium leakage can lead to mild polyuria of type 3 ABS. Urine sodium of type 3 ABS was as low as 22 mmol/L compared with 60 mmol/L for type 1, 82 mmol/L for type 2 and 82 mmol/L for type 4a.8 The pathogenesis of BS is salt loss on the ureteral side, which results in migration of fluid and increased urine output. Type 3 ABS patients have low sodium leakage into the urine, which results in low urine output. We consider this to be the reason why polyuria is mild in patients with type 3 ABS. In our present case, urine sodium was as high as 39 to 96 mmol/L; however, these samples were obtained after sodium supplementation. Immature sodium reabsorption function of the renal tubule in preterm infants may also affect the high sodium excretion in urine in our case. Nephrotic diabetes insipidus can cause polyuria in the foetal and neonatal periods like ABS but does not cause polyhydramnios at a similar rate to ABS. The urinary and amniotic fluid components of ABS are salt and water, whereas those of nephrotic diabetes insipidus are pure water. Sodium and chloride in the amniotic fluid can lead to the retention of water; therefore, ABS results in polyhydramnios much more than nephrotic diabetes insipidus.9 This suggests that lower urine sodium leakage in the amniotic fluid will less likely lead to polyhydramnios and subsequent preterm delivery. Therefore, among all ABS types, type 3 ABS, with the lowest urinary sodium leakage rate, is less likely to result in the development of polyhydramnios and induce preterm delivery.

The reason why type 3 ABS presents with low sodium excretion is unclear. Type 3 ABS is caused by chloride-channel kb dysfunction, which resides in both the Henle’s loop and distal tubule.10 Based on the results of diuretic studies, it has been reported that type 3 BS is not caused by Henle’s loop, but is caused by distal tubular dysfunction.1 Henle’s loop reabsorbs more sodium than the distal tubule; therefore, type 3 ABS with distal tubular dysfunction may lead to less urinary sodium leakage and mild polyuria than other types.

However, the association between mutations and symptoms of CLCNKB gene remain unclear. In a study of five children with homozygous deletion of the whole CLCNKB gene, two patients had a history of polyhydramnios, which presented at 0.5–12 months of age.11 In this case with two large gene deletions, the patient presented with mild polyuria. Although further studies are required for evidence, large deletions of CLCNKB gene may not necessarily indicate severe symptoms at the antenatal/neonatal period.

Our study had some limitations. First, the patient had intrauterine infection, which could have affected the decreasing renal circulation from the foetal period. Treatment with gentamicin may also have affected the electrolyte leakage from the tubules. In addition, significant postnatal weight loss may have suggested dehydration and reduced polyuria, which could have led to less urinary sodium leakage during the perinatal period.

Patient’s perspective

His mother says that ‘I’m shocked that our child has a very rare autosomal recessive disorder and may continue taking medicine or supplement until the end of his life. But I want to support him as a member of the family.’ His father says that ‘I support him and my wife.’

Learning points

  • Patients with type 3 antenatal Bartter syndrome (ABS) can develop mild polyuria.

  • Type 3 ABS is more likely to have milder polyuria than other types.

  • Mild polyuria results in mild polyhydramnios, which reduces the likelihood of preterm delivery.

  • Our case plays an important role in elucidating the pathogenesis of term births for patients with type 3 ABS.

Footnotes

  • Contributors YO cared for the patient, drafted the initial manuscript and reviewed and revised the manuscript. YK, HS and SY critically reviewed the manuscript for important intellectual content. All authors have read and approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer